These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8545465)

  • 1. Serotonergic stimulation of the ventrolateral striatum induces orofacial stereotypy.
    Yeghiayan SK; Kelley AE
    Pharmacol Biochem Behav; 1995 Nov; 52(3):493-501. PubMed ID: 8545465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum.
    Kelley AE; Delfs JM
    Neuroscience; 1994 May; 60(1):85-95. PubMed ID: 7914360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dopamine in behavioral effects of serotonin microinjected into rat striatum.
    Yeghiayan SK; Kelley AE; Kula NS; Campbell A; Baldessarini RJ
    Pharmacol Biochem Behav; 1997 Feb; 56(2):251-9. PubMed ID: 9050082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study.
    Dickson PR; Lang CG; Hinton SC; Kelley AE
    Neuroscience; 1994 Jul; 61(1):81-91. PubMed ID: 7969898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
    De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
    Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum.
    De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U
    J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content.
    Kostrzewa RM; Brus R; Perry KW; Fuller RW
    Acta Neurobiol Exp (Wars); 1996; 56(1):21-8. PubMed ID: 8787176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo electrochemical studies of gradient effects of (SC) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats.
    Broderick PA
    Pharmacol Biochem Behav; 1993 Dec; 46(4):973-84. PubMed ID: 8309978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.
    Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH
    Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM; Gresch PJ; Walker PD
    Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of escitalopram and a 5-HT(₁A) receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT(₂C) receptor stimulation; suggestive of antipsychotic potential.
    Hovelsø N; Sager TN; Mørk A
    Pharmacol Biochem Behav; 2011 Jan; 97(3):479-85. PubMed ID: 20937301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors.
    Wong PT; Feng H; Teo WL
    Neurosci Res; 1995 Aug; 23(1):115-9. PubMed ID: 7501296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.